Influenza hemagglutinin-specific T-cell receptor (HA-specific TCR)

Influenza hemagglutinin-specific T-cell receptors (HA-specific TCRs) are specialized heterodimeric surface proteins on T lymphocytes that recognize peptide fragments of the influenza hemagglutinin (HA) protein presented by Major Histocompatibility Complex (MHC) molecules (PubMed: 25108025). These receptors are pivotal in the adaptive immune response, enabling CD4+ and CD8+ T cells to identify and eliminate virus-infected cells or provide help for B-cell antibody production (NCBI: NBK27146). In the pharmaceutical industry, HA-specific TCRs are primarily targeted through the development of adoptive T-cell therapies (TCR-T) and next-generation vaccines designed to elicit broad, cross-protective cellular immunity against diverse influenza strains (PubMed: 30104370). The specificity of these TCRs is determined by the unique arrangement of their alpha and beta chains, which bind to the HA-peptide-MHC complex with varying affinities. Therapeutic strategies involving these TCRs focus on enhancing the magnitude and breadth of the T-cell response to overcome the challenges of antigenic drift in influenza viruses. For instance, TCRs targeting conserved HA epitopes, such as the HA306-318 peptide presented by HLA-DR1, are of significant interest for universal vaccine design (UniProt: P01859). However, the clinical application of TCR-based therapies must address potential safety concerns, including off-target cross-reactivity with human self-peptides and the risk of cytokine release syndrome (PubMed: 29439166). Monitoring the efficacy of such interventions often involves the use of peptide-MHC multimers and TCR repertoire sequencing to track the expansion of specific T-cell clones (PubMed: 26109305).

Other names

HA-specific TCRInfluenza HA-reactive T-cell receptorHemagglutinin-specific T-cell receptorHA-peptide-MHC-specific TCRT-cell receptor specific for influenza HA

The mechanism of action involves the high-affinity binding of the TCR to a specific influenza HA peptide (e.g., HA306-318) nestled within the groove of an MHC molecule. This binding event triggers the clustering of the TCR-CD3 complex, leading to the phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) by Src-family kinases like Lck. This initiates a downstream signaling cascade involving ZAP-70 and LAT, ultimately resulting in T-cell proliferation, the release of effector cytokines (such as IFN-gamma and TNF-alpha), and, in the case of CD8+ T cells, the directed lysis of infected host cells (NCBI: NBK27146; PubMed: 25108025).